- Home
- NNVC vs VTGN Comparison
NNVC vs VTGN Comparison
Compare NNVC & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNVC | VTGN |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 24.1M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NNVC | VTGN |
|---|---|---|
| Price | $1.25 | $0.59 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 215.0K | ★ 648.3K |
| Earning Date | 05-14-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $0.43 |
| 52 Week High | $2.23 | $5.14 |
Technical Indicators
Market Signals| Indicator | NNVC | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 48.76 |
| Support Level | $1.09 | $0.57 |
| Resistance Level | $1.29 | $0.60 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 52.69 | 56.86 |
Price Performance
Historical ComparisonAbout NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.